Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBIDS.L Regulatory News (BIDS)

  • There is currently no data for BIDS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of Fitbug KiK Plan and £1,000,000 Loan

11 Feb 2014 07:00

RNS Number : 7364Z
Fitbug Holdings PLC
11 February 2014
 



Fitbug Holdings Plc / Epic: FITB.L / Index: AIM / Sector: Leisure

11 February 2014

Fitbug Holdings Plc ('Fitbug' or 'the Company')

Very strong market response to launch of Fitbug KiK plan coaching programmes at CES

Secures £1,000,000 Loan on Attractive Terms

 

Fitbug Holdings Plc, the AIM listed provider of online personal health and well-being services, is pleased to announce that its Fitbug KiK coaching plans have received a very strong market response following its official launch at the 2014 Consumer Electronics Show ('CES') held in Las Vegas in January 2014. Additionally, the Company reports that it has signed a £1 million loan agreement ('the Loan') with NW1 Investments Limited ('Loan Holder').

 

Wearable devices, or "wearables" were widely recognised as the fastest growing product category at CES 2014, with the Financial Times reporting that "Wearables emerge as top CES trend" on 6 January 2014. In line with this, Fitbug announced the "next step" in the digital health ecosystem, unveiling KiKplanTM, an advanced personalised coaching aid designed to work with activity trackers to meet specific health, weight and fitness goals. Media and market reaction has been very positive following the launch, with the Huffington Post singling out Fitbug as one of five companies "Changing the game in 2014" (please see http://huff.to/1dtsolx).  Additionally, in its January Wireless and Cloud Computing Update, JMP Securities included Fitbug in "The JMP Securities Fit 50: The Hottest mHealth and mFitness players from the ranks of private or lesser known technology companies."

 

In response to the very strong retail interest in wearables at CES, Fitbug is now putting retail distribution arrangements in place in the US, UK, Europe, Middle East, Asia and Australia. 

 

Fitbug Executive Chairman Fergus Kee said, "It is clear that 2014 will see the relevance of wearable devices move from niche applications into much more mainstream products and markets. The mHealth and mFitness industries are now poised for strong growth and we believe that Fitbug is well placed to share in that growth." 

 

To support planned growth in 2014 the Company has signed a £1 million loan agreement with NW1 Investments Limited. The Loan is repayable by 31 July 2014 and will accrue interest at a rate of 5% per annum, payable on a quarterly basis. If during the term of the Loan Fitbug undertakes an equity issue, the Loan Holder can elect to convert some or the entire Loan into new ordinary shares in Fitbug. NW1 Investments Limited is a company in which the family of David Turner and Allan Fisher, both directors of Fitbug, have a material interest.

 

The independent directors of the Company, being Fergus Kee, Paul Landau, Andrew Brummer and Geoffrey Simmonds, consider, having consulted with Cantor Fitzgerald Europe, that the terms of the Loan are fair and reasonable in so far as the shareholders are concerned.

 

 

**ENDS**

 

For further information contact:

 

Paul Landau/Andrew Brummer

Fitbug Holdings Plc

020 7449 1000

Mark Percy/Catherine Leftley/Katie Ratner

Cantor Fitzgerald Europe

020 7894 7000

Claire Louise Noyce / William Lynne

Hybridan LLP

020 7947 4350 / 020 7947 4361

Elisabeth Cowell/Charlotte Heap

St Brides Media & Finance Ltd

020 7236 1177

 

 

Notes

 

Fitbug is a leading provider of online health and well-being services to help individuals to improve their lifestyles by making realistic changes to their daily routine. It combines activity tracking devices, which download to fitbug.com to provide an understanding of each user's daily activity achievements, with web technology which provides users with personalised weekly activity and nutrition targets, feedback, advice and encouragement.

 

Key market sectors include health insurance and rewards providers, workplace health programmes, Primary Care Trusts, fitness operators and consumers. Increasingly, Fitbug's platform acts as the driving force behind third party services such as white label sites, activity driven games and challenge microsites and rewards programmes. The Company's main focus is now on building strategic partnerships with organisations that can integrate Fitbug into their own service/product offerings or resell to their customer base. The Company has operations in Australia and Asia, with the United States remaining the primary market. For more information, visit www.fitbug.com.

 

The Fitbug business was founded by Paul Landau, CEO of Fitbug Limited. Fergus Kee, Executive Chairman of the Company is the former Managing Director of Bupa's £2.1 billion turnover UK and North American Division.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PRLLLFLTFFIILIS
Date   Source Headline
23rd Apr 20247:00 amRNSCancellation - Bidstack Group PLC
22nd Mar 20241:11 pmRNSAppointment of Administrators & Nomad Resignation
11th Mar 20247:30 amRNSSuspension - Bidstack Group PLC
11th Mar 20247:00 amRNSIntention to Appoint Administrators & Suspension
5th Feb 20247:00 amRNSUpdate on CLN, Financial Update & Strategic Review
22nd Dec 20237:00 amRNSSettlement & new commercial partnership - Azerion
1st Nov 20237:00 amRNSChange of Registered Office
18th Oct 20233:45 pmRNSProposed CLN, Share Reorganisation and VST Update
29th Sep 20237:00 amRNSBoard Change
29th Sep 20237:00 amRNSProposed New Commercial Partnership
29th Sep 20237:00 amRNSInterim Results
30th Aug 20237:00 amRNSVenatus Advertising Sales Partnership
23rd Aug 20234:47 pmRNSTR-1: Notification of Major Holdings
21st Jul 202311:23 amRNS2023 Annual General Meeting Results
18th Jul 202311:46 amRNSGeneral Meeting Requisition Request withdrawn
18th Jul 20237:00 amRNSBoard Changes
13th Jul 20231:32 pmRNSVirtual stadium partnership with first NFL team
11th Jul 20237:00 amRNSRequisitioned General Meeting
5th Jul 20237:00 amRNSRequest to requisition a General Meeting
21st Jun 20237:00 amRNSAnnual Report & Accounts and Notice of AGM
20th Jun 20238:18 amRNSFinal Results and Annual Report - replacement
20th Jun 20237:00 amRNSAnnual Report & Accounts and Notice of AGM
1st Mar 20235:28 pmRNSComment on Azerion Statement
15th Feb 20237:00 amRNSBidstack appoints Thomas Bullen as CFO
13th Feb 20232:05 pmRNSSecond Price Monitoring Extn
13th Feb 20232:00 pmRNSPrice Monitoring Extension
13th Feb 20237:00 amRNSTrading and Operational Update
18th Jan 202311:22 amRNSChange of Registered Office
3rd Jan 202311:05 amRNSSecond Price Monitoring Extn
3rd Jan 202311:00 amRNSPrice Monitoring Extension
3rd Jan 20237:00 amRNSAzerion Update
29th Dec 20227:00 amRNSBoard Changes
9th Dec 202211:04 amRNSGrant of LTIP Options
8th Dec 20227:00 amRNSExercise of Options, Issue of Equity & TVR
6th Dec 202211:03 amRNSTR-1: Notification of major holdings
5th Dec 20227:00 amRNSBidstack adds 2 titles with a AAA game publisher
1st Nov 20223:39 pmRNSTR-1: Notification of major holdings
31st Oct 20223:35 pmRNSTotal Voting Rights
31st Oct 20223:21 pmRNSTR-1: Notification of major holdings
31st Oct 20222:16 pmRNSTR-1: Notification of major holdings
31st Oct 202211:54 amRNSTR-1: Notification of major holdings
28th Oct 20224:16 pmRNSTR-1: Notification of Major Holdings
28th Oct 20227:00 amRNSUpdate re Press Commentary
26th Oct 20223:45 pmRNSAdmission of Ordinary Shares and TVR
26th Oct 20227:00 amRNSStrategy Update
25th Oct 202212:08 pmRNSResults of General Meeting
13th Oct 20227:00 amRNSBidstack appoints Camila Franklin as COO
6th Oct 20226:28 pmRNSResults of REX Retail Offer
6th Oct 20228:06 amRNSResults of Placing and Subscription
5th Oct 20224:36 pmRNSREX Retail Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.